- Home
- SVRA vs SCVL Comparison
SVRA vs SCVL Comparison
Compare SVRA & SCVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- SCVL
- Stock Information
- Founded
- SVRA 2007
- SCVL 1978
- Country
- SVRA United States
- SCVL United States
- Employees
- SVRA N/A
- SCVL N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- SCVL Clothing/Shoe/Accessory Stores
- Sector
- SVRA Health Care
- SCVL Consumer Discretionary
- Exchange
- SVRA Nasdaq
- SCVL Nasdaq
- Market Cap
- SVRA 527.2M
- SCVL 608.5M
- IPO Year
- SVRA N/A
- SCVL 1993
- Fundamental
- Price
- SVRA $3.95
- SCVL $17.48
- Analyst Decision
- SVRA Buy
- SCVL Hold
- Analyst Count
- SVRA 8
- SCVL 1
- Target Price
- SVRA $6.88
- SCVL N/A
- AVG Volume (30 Days)
- SVRA 1.7M
- SCVL 375.2K
- Earning Date
- SVRA 11-13-2025
- SCVL 11-20-2025
- Dividend Yield
- SVRA N/A
- SCVL 3.45%
- EPS Growth
- SVRA N/A
- SCVL N/A
- EPS
- SVRA N/A
- SCVL 2.27
- Revenue
- SVRA N/A
- SCVL $1,153,927,000.00
- Revenue This Year
- SVRA N/A
- SCVL N/A
- Revenue Next Year
- SVRA N/A
- SCVL $2.07
- P/E Ratio
- SVRA N/A
- SCVL $7.66
- Revenue Growth
- SVRA N/A
- SCVL N/A
- 52 Week Low
- SVRA $1.89
- SCVL $16.14
- 52 Week High
- SVRA $4.51
- SCVL $39.29
- Technical
- Relative Strength Index (RSI)
- SVRA 50.44
- SCVL 36.82
- Support Level
- SVRA $4.14
- SCVL $16.76
- Resistance Level
- SVRA $4.51
- SCVL $18.31
- Average True Range (ATR)
- SVRA 0.22
- SCVL 0.72
- MACD
- SVRA -0.05
- SCVL -0.12
- Stochastic Oscillator
- SVRA 11.63
- SCVL 19.64
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About SCVL Shoe Carnival Inc.
Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.